Teresa Lopez explores the critical relationship between oncolysis treatments and myocardial damage. She discusses the importance of early detection, risk assessment, and monitoring strategies to anticipate and mitigate potential cardiac complications in cancer patients. Using advanced imaging techniques and clinical biomarkers, Lopez highlights how healthcare professionals can proactively manage cardiotoxicity risks, ensuring better patient outcomes. This video is a valuable resource for medical professionals, researchers, and anyone interested in the intersection of oncology and cardiology.